menu search

BIO / Bio-Rad Laboratories, Inc. (BIO) Q4 2022 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (BIO) Q4 2022 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q4 2022 Earnings Conference Call February 16, 2023 5:00 PM ET Company Participants Edward Chung - Vice President, Investor Relations Ilan Daskal - Chief Financial Officer Andrew Last - Chief Operating Officer Norman Schwartz - President and Chief Executive Officer Simon May - President, Life Science Group Conference Call Participants Patrick Donnelly - Citigroup Inc. Dan Leonard - Credit Suisse Brandon Couillard - Jefferies Group LLC Jack Meehan - Nephron Research LLC Operator Good afternoon, ladies and gentlemen. Thank you for attending today's Bio-Rad Fourth Quarter and Full Year 2022 Earnings Results Conference Call. Read More
Posted: Feb 16 2023, 23:13
Author Name: Seeking Alpha
Views: 092184

BIO News  

Bio-Rad (BIO) Misses Q3 Earnings Estimates, Cuts 2023 View

By Zacks Investment Research
October 27, 2023

Bio-Rad (BIO) Misses Q3 Earnings Estimates, Cuts 2023 View

The deterioration in biopharma and early biotech customer spending and a challenging macroeconomic environment in China impact Bio-Rad's (BIO) Q3 perf more_horizontal

Bio-Rad Laboratories, Inc. (BIO) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

Bio-Rad Laboratories, Inc. (BIO) Q3 2023 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q3 2023 Results Conference Call October 26, 2023 5:00 PM ET Company Participants Edward Chung - Head, IR Norman more_horizontal

Bio-Rad Laboratories (BIO) to Post Q3 Earnings: What Awaits?

By Zacks Investment Research
October 20, 2023

Bio-Rad Laboratories (BIO) to Post Q3 Earnings: What Awaits?

Bio-Rad (BIO) Life Science segment will likely have witnessed growth in Q3, driven by Droplet Digital PCR and qPCR products. more_horizontal

New Strong Sell Stocks for September 19th

By Zacks Investment Research
September 19, 2023

New Strong Sell Stocks for September 19th

BIO, LPG and COLB have been added to the Zacks Rank #5 (Strong Sell) List on September 19, 2023. more_horizontal

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

By InvestorPlace
September 2, 2023

3 Beaten-Down Biotech Stocks Bound for a Bounce Back

Biotech stocks soared high during the COVID-19 pandemic, as they were our only hope for new drugs and vaccines to fight the virus. However, the biotec more_horizontal

New Strong Sell Stocks for August 18th

By Zacks Investment Research
August 18, 2023

New Strong Sell Stocks for August 18th

BIO, REFI and GPK have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2023. more_horizontal

Bio-Rad (BIO) Beats on Q2 Earnings Estimates, Cuts 2023 View

By Zacks Investment Research
August 4, 2023

Bio-Rad (BIO) Beats on Q2 Earnings Estimates, Cuts 2023 View

Growth across the Life Science portfolio and strong double-digit growth for ddPCR drive Bio-Rad (BIO) Q2 performance. more_horizontal

Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 3, 2023

Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript

Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Edward Chung - Head, Investor R more_horizontal


Search within

Pages Search Results: